Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
Heart
    October 2026
  1. CHRISTENSEN MK, Pedersen AK, Hyldgard VB, Moller JE, et al
    Timing of heart failure diagnosis and uptake of newly recommended therapies following clinical guideline updates.
    Heart. 2026 Oct 8:heartjnl-2025-327578. doi: 10.1136/heartjnl-2025-327578.
    >> Share

    September 2026
  2. IACOVELLI JJ, Wray DW, Carter SJ
    Reframing transthyretin amyloidosis cardiomyopathy in the context of heart failure.
    Heart. 2026 Sep 16:heartjnl-2026-328728. doi: 10.1136/heartjnl-2026-328728.
    >> Share

  3. GUDER G, Stork S, Frantz S, Sahiti F, et al
    Discordance between N-terminal pro-B-type natriuretic peptide and left ventricular end-diastolic pressure in suspected heart failure with a preserved ejection fraction: implications for diagnosis and prognosis.
    Heart. 2026 Sep 15:heartjnl-2026-328688. doi: 10.1136/heartjnl-2026-328688.
    >> Share

    August 2026
  4. ERHARDSSON M, Lund L, Benson L, Savarese G, et al
    Weight loss as a marker of successful decongestion during acute heart failure hospitalisation.
    Heart. 2026 Aug 25:heartjnl-2026-328175. doi: 10.1136/heartjnl-2026-328175.
    >> Share

  5. SCHIOPU A, Svedlund S, Narasimhan G, Juin Loong B, et al
    Circulating soluble LOX-1 and patient prognosis after an acute coronary syndrome.
    Heart. 2026;112:1014-1021.
    >> Share

  6. INUKAI K, Takefuji M, Kazama S, Ito R, et al
    Prognostic and exploratory neurohormonal correlates of hypochloraemia in heart failure: a multicentre cohort study.
    Heart. 2026 Aug 20:heartjnl-2026-328053. doi: 10.1136/heartjnl-2026-328053.
    >> Share

  7. PACK SJJ, Sawant S, Abhayaratna C, Wang N, et al
    Effects of pharmacological blood pressure lowering in heart failure with mildly reduced or preserved ejection fraction: a meta-analysis.
    Heart. 2026 Aug 7:heartjnl-2026-327872. doi: 10.1136/heartjnl-2026-327872.
    >> Share

  8. GILL A, Li T, Jimenez S, Cadeiras M, et al
    Bidirectional links between heart failure and cancer: shared pathophysiology, clinical outcomes and collaborative management.
    Heart. 2026 Aug 3:heartjnl-2026-328221. doi: 10.1136/heartjnl-2026-328221.
    >> Share

    July 2026
  9. MIRZOHREH ST, Deravi N, Javanshir E, Asghari Jafarabadi M, et al
    Impact of diabetes on outcomes in hypertrophic cardiomyopathy: a GRADE meta-analysis.
    Heart. 2026;112:876-888.
    >> Share

    June 2026
  10. PNG ME, Tahsina T, Jones NR, Taylor CJ, et al
    Cost-effectiveness of N-terminal pro-B-type natriuretic peptide thresholds for echocardiography referral in primary care heart failure management.
    Heart. 2026 Jun 26:heartjnl-2026-328059. doi: 10.1136/heartjnl-2026-328059.
    >> Share

  11. NOMA H, Kurita N, Fukuma S, Fujisawa T, et al
    Heart failure and renal outcomes with angiotensin receptor blockers compared with calcium channel blockers in patients with chronic kidney disease: a target trial emulation.
    Heart. 2026 Jun 23:heartjnl-2026-328193. doi: 10.1136/heartjnl-2026-328193.
    >> Share

  12. BERNARD A
    Aortic stenosis in patients with heart failure: anything but benign.
    Heart. 2026 Jun 2:heartjnl-2025-327713. doi: 10.1136/heartjnl-2025-327713.
    >> Share

    May 2026
  13. SHERGILL S, Dattani A, Kanagala P, Singh A, et al
    Prognostic value of pulmonary transit time by cardiovascular MRI in heart failure with preserved ejection fraction.
    Heart. 2026 May 28:heartjnl-2026-328139. doi: 10.1136/heartjnl-2026-328139.
    >> Share

  14. CELUTKIENE J
    Against the odds: improving survival in acute heart failure.
    Heart. 2026 May 13:heartjnl-2026-328004. doi: 10.1136/heartjnl-2026-328004.
    >> Share

  15. LOGEART D, Alos B, Legalloisl D, Guillaume C, et al
    Temporal trends in characteristics, management and prognosis of patients with acute heart failure through two repeated snapshots.
    Heart. 2026 May 13:heartjnl-2025-327454. doi: 10.1136/heartjnl-2025-327454.
    >> Share

  16. GONZALEZ-MANZANARES R, Rossello X
    Methodological lessons of implementation trials in heart failure.
    Heart. 2026 May 8:heartjnl-2026-328160. doi: 10.1136/heartjnl-2026-328160.
    >> Share

    April 2026
  17. FUSCO F, Scognamiglio G, Dellborg M, Dehghani P, et al
    Cardiac resynchronisation therapy among adults with a systemic right ventricle: a multicentre experience.
    Heart. 2026;112:549-556.
    >> Share

  18. NAVARRO JM, Doumouras BS, Douglas W, Tieu P, et al
    Risk prediction models for incident heart failure: a systematic review and meta-analysis.
    Heart. 2026 Apr 20:heartjnl-2025-327118. doi: 10.1136/heartjnl-2025-327118.
    >> Share

  19. SHIRAISHI Y, Ikemura N, Ueda I, Kohno T, et al
    Comprehensive guideline-directed medical therapy strategies on health status outcomes in patients with heart failure: the LAQUA-HF randomised clinical trial.
    Heart. 2026 Apr 20:heartjnl-2025-327642. doi: 10.1136/heartjnl-2025-327642.
    >> Share

    March 2026
  20. MI L, Chan JSK, Wong WT, Tse G, et al
    Parsimonious echocardiography-based model for predicting long-term all-cause mortality in heart failure with preserved ejection fraction.
    Heart. 2026 Mar 24:heartjnl-2026-327898. doi: 10.1136/heartjnl-2026-327898.
    >> Share


  21. Correction: Atrial fibrillation and heart failure with preserved ejection fraction: diagnostic challenges and therapeutic opportunities.
    Heart. 2026;112:e3.
    >> Share

  22. MARIANI A, Luckham K, Miles L, Samarasekera E, et al
    Model-based cost-effectiveness analysis of first-line pharmacotherapy combinations in adults with chronic heart failure and reduced ejection fraction.
    Heart. 2026 Mar 11:heartjnl-2025-327190. doi: 10.1136/heartjnl-2025-327190.
    >> Share

  23. AVERBUCH T, Greene S, Biering-Sorensen T, Kotwal S, et al
    Burden of chronic kidney disease and outcomes following hospitalisation for heart failure.
    Heart. 2026 Mar 3:heartjnl-2025-327053. doi: 10.1136/heartjnl-2025-327053.
    >> Share

  24. KOBAYASHI M
    Kidney decline: an overlooked driver of mortality and healthcare burden following heart failure hospitalisation.
    Heart. 2026 Mar 3:heartjnl-2025-327647. doi: 10.1136/heartjnl-2025-327647.
    >> Share

    February 2026
  25. SATO R, Schmidt C, von Haehling S
    Invisible threats, visible consequences: metabolomic footprints of air pollution on heart failure.
    Heart. 2026 Feb 27:heartjnl-2026-327798. doi: 10.1136/heartjnl-2026-327798.
    >> Share

  26. SINAN UY
    Guideline-directed medical therapy in older heart failure patients: survival gains, evidence gaps and the challenge of implementation.
    Heart. 2026 Feb 26:heartjnl-2026-327799. doi: 10.1136/heartjnl-2026-327799.
    >> Share

  27. AZAR M, Apostolo A, Salvioni E, Galotta A, et al
    Cardiopulmonary exercise test criteria for heart transplantation referral of patients with ambulatory heart failure in the current era.
    Heart. 2026 Feb 11:heartjnl-2025-327208. doi: 10.1136/heartjnl-2025-327208.
    >> Share

  28. TAN E, Meei-Wah C, Teo YH, Tan LF, et al
    Survival benefit of guideline-directed medical therapy in older patients with heart failure: a systematic review and meta-analysis.
    Heart. 2026 Feb 11:heartjnl-2025-326305. doi: 10.1136/heartjnl-2025-326305.
    >> Share

  29. LUO E, Cuthbert JJ, Kazmi S, Rigby AS, et al
    Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failure.
    Heart. 2026 Feb 9:heartjnl-2025-327093. doi: 10.1136/heartjnl-2025-327093.
    >> Share

  30. VERELST F, Witte KK, Ahmed FZ, Al-Khatib SM, et al
    Atrial fibrillation and heart failure with preserved ejection fraction: diagnostic challenges and therapeutic opportunities.
    Heart. 2026 Feb 5:heartjnl-2025-326954. doi: 10.1136/heartjnl-2025-326954.
    >> Share

    January 2026
  31. HEITZINGER G, Torrefranca CS, Koschatko S, Jantsch C, et al
    Impact and prognostic implications of aortic stenosis across the heart failure spectrum: a cohort study.
    Heart. 2026 Jan 21:heartjnl-2025-326808. doi: 10.1136/heartjnl-2025-326808.
    >> Share

  32. YANG C, Fan Z, Zhang J, Wu H, et al
    Air pollution-related metabolic profiles and subsequent heart failure risk.
    Heart. 2026 Jan 21:heartjnl-2025-326668. doi: 10.1136/heartjnl-2025-326668.
    >> Share

  33. HERRMANN JJ, van Berlo R, Brunner-La Rocca HP, Sanders-Van Wijk S, et al
    Fluid restriction in patients with heart failure: a systematic review.
    Heart. 2026 Jan 13:heartjnl-2025-326784. doi: 10.1136/heartjnl-2025-326784.
    >> Share

  34. SATO R, Schmidt C, von Haehling S
    Heart failure and fluid restriction: time to let go?
    Heart. 2026 Jan 13:heartjnl-2025-327288. doi: 10.1136/heartjnl-2025-327288.
    >> Share

  35. CLARK AL, Omar RZ, Ambler G, Qu C, et al
    Predicting 30-day mortality after hospital admission for heart failure: the National Heart Failure Audit for England and Wales.
    Heart. 2026 Jan 6:heartjnl-2025-326731. doi: 10.1136/heartjnl-2025-326731.
    >> Share

    December 2025
  36. AHMED FZ, Harwood R, Lanctin D, Leonard C, et al
    Economic evaluation of the TriageHF Plus clinical pathway for device-based remote monitoring in heart failure.
    Heart. 2025 Dec 17:heartjnl-2025-326702. doi: 10.1136/heartjnl-2025-326702.
    >> Share

  37. KIM CK, Jo S, Ha K, Kim B, et al
    Metabolic dysfunction-associated steatotic liver disease and risk of heart failure: a nationwide cohort study.
    Heart. 2025 Dec 15:heartjnl-2025-327102. doi: 10.1136/heartjnl-2025-327102.
    >> Share

  38. ZAGHI A, Jujic A, Zilic H, Dieden A, et al
    Impact of cerebral oxygen saturation on mortality and rehospitalisation in patients with heart failure and the role of physical activity as a modifying factor: the HARVEST-Malmo Study.
    Heart. 2025 Dec 9:heartjnl-2025-326503. doi: 10.1136/heartjnl-2025-326503.
    >> Share

    November 2025
  39. SHOJI S, Wilson N, Levitan EB, Judd SE, et al
    Isolated non-specific electrocardiographic ST-T abnormalities and risk of incident heart failure and its subtypes.
    Heart. 2025 Nov 17:heartjnl-2025-326798. doi: 10.1136/heartjnl-2025-326798.
    >> Share

  40. MONZO L, Huttin O, Bozkurt B, Duarte K, et al
    Comparing diagnostic tools for heart failure with preserved ejection fraction across community and clinical cohorts.
    Heart. 2025 Nov 17:heartjnl-2025-326517. doi: 10.1136/heartjnl-2025-326517.
    >> Share

  41. NAHIZ N, Jakobsen JC, Lukoschewitz JD, Doleman B, et al
    Combinations of diuretics for acute heart failure: a systematic review with network meta-analysis and trial sequential analysis.
    Heart. 2025 Nov 13:heartjnl-2025-326601. doi: 10.1136/heartjnl-2025-326601.
    >> Share

  42. PARENTE HA, Oliveira MDSS, Cordeiro JVFA, Sforza LM, et al
    Levosimendan versus dobutamine in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
    Heart. 2025 Nov 12:heartjnl-2025-326744. doi: 10.1136/heartjnl-2025-326744.
    >> Share

  43. WATANABE A, Miyamoto Y, Ueyama HA, Inoue K, et al
    Percutaneous ventricular assist devices for percutaneous coronary interventions in older patients with heart failure: a target trial emulation.
    Heart. 2025 Nov 11:heartjnl-2025-326949. doi: 10.1136/heartjnl-2025-326949.
    >> Share

    October 2025
  44. WANDER G, van der Zande JA, Canpolat U, Bouchardy J, et al
    Twin pregnancies in women with heart disease are complicated by high risk of heart failure: data from the EORP ROPAC Registry.
    Heart. 2025 Oct 23:heartjnl-2025-326281. doi: 10.1136/heartjnl-2025-326281.
    >> Share

  45. MONTANARO C, Mihailescu A, Sabatino J
    Twin gestation unmasks heart failure risk in women with cardiac disease.
    Heart. 2025 Oct 23:heartjnl-2025-327176. doi: 10.1136/heartjnl-2025-327176.
    >> Share

  46. ZHANG C, Zhong Y, Li Q, Song G, et al
    Prospective multicentre single-arm study of an interatrial shunt in heart failure with reduced ejection fraction (SUSTAIN-HF): 1-year clinical and haemodynamic outcomes.
    Heart. 2025 Oct 17:heartjnl-2025-326319. doi: 10.1136/heartjnl-2025-326319.
    >> Share

  47. KILIC ME, Arayici ME, Yilancioglu RY, Turan OE, et al
    Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis.
    Heart. 2025 Oct 6:heartjnl-2025-326174. doi: 10.1136/heartjnl-2025-326174.
    >> Share

    September 2025
  48. MU L, Larvin H, Nadarajah R, Gale CP, et al
    Long-term cardiovascular risks after atrial fibrillation diagnosis: a systematic review and meta-analysis.
    Heart. 2025 Sep 17:heartjnl-2025-326376. doi: 10.1136/heartjnl-2025-326376.
    >> Share

  49. LIAO LP, Church LA, Melville H, Jayasinghe T, et al
    Effect of ketone supplementation, a low-carbohydrate diet and a ketogenic diet on heart failure measures and outcomes: a systematic review and meta-analysis.
    Heart. 2025 Sep 16:heartjnl-2025-326082. doi: 10.1136/heartjnl-2025-326082.
    >> Share

  50. RAHIMI K, Gerdts E
    Beyond hypertension: quantifying the full risk landscape for heart failure in women.
    Heart. 2025 Sep 3:heartjnl-2025-326874. doi: 10.1136/heartjnl-2025-326874.
    >> Share

    August 2025
  51. DE JUAN BAGUDA J, Severo Sanchez A, de la Espriella R, Valero-Masa MJ, et al
    Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis.
    Heart. 2025 Aug 28:heartjnl-2025-326053. doi: 10.1136/heartjnl-2025-326053.
    >> Share

  52. BEREZIN A
    Carbohydrate antigen 125: promising diagnostic biomarker in heart failure with preserved ejection fraction.
    Heart. 2025 Aug 28:heartjnl-2025-326900. doi: 10.1136/heartjnl-2025-326900.
    >> Share

  53. BUYADAA O, Wolfe R, Tonkin AM, Reid CM, et al
    Kidney function and risk of heart failure in older adults: findings from a prospective cohort study.
    Heart. 2025 Aug 22:heartjnl-2025-325700. doi: 10.1136/heartjnl-2025-325700.
    >> Share

  54. JIANG M, Zhou W, Qiao HY, Zheng T, et al
    Phenotypic stratification and prognostic value of cardiac magnetic resonance in non-dilated left ventricular cardiomyopathy.
    Heart. 2025 Aug 17:heartjnl-2025-326192. doi: 10.1136/heartjnl-2025-326192.
    >> Share

  55. PROIETTI M, Romiti GF
    Cardiac cachexia and sarcopenia in patients with heart failure: need for an integrated approach to patients with chronic cardiovascular diseases.
    Heart. 2025 Aug 4:heartjnl-2025-325988. doi: 10.1136/heartjnl-2025-325988.
    >> Share

  56. SHAN S, Sun W, Wu J, Zhu Y, et al
    Population attributable risk of traditional, under-recognised and female-specific factors for heart failure in women.
    Heart. 2025 Aug 4:heartjnl-2025-326345. doi: 10.1136/heartjnl-2025-326345.
    >> Share

  57. SOTOMI Y, Matsuoka Y, Ebert C, Wang Z, et al
    Subphenogroups of acute heart failure with preserved ejection fraction: comprehensive proteomics and pathway analysis.
    Heart. 2025 Aug 1:heartjnl-2025-326091. doi: 10.1136/heartjnl-2025-326091.
    >> Share

    July 2025
  58. MATTIG I, Romero Dorta E, Frumkin D, Kretzschmar H, et al
    Sex differences in the prevalence and prognosis of tricuspid regurgitation among patients with heart failure.
    Heart. 2025 Jul 24:heartjnl-2025-325913. doi: 10.1136/heartjnl-2025-325913.
    >> Share

  59. SCIATTI E, Di Odoardo L, Zucchetti O, Senni M, et al
    Vericiguat in advanced heart failure patients receiving chronic intermittent levosimendan infusions: a prospective pilot study.
    Heart. 2025 Jul 14:heartjnl-2025-326009. doi: 10.1136/heartjnl-2025-326009.
    >> Share

  60. LI H, Li L, Zou J
    Case of atypical heart failure in a middle-aged male.
    Heart. 2025;111:715-744.
    >> Share

    June 2025
  61. REDDY YNV, Miranda WR
    Haemodynamic-guided and device-free shunting for heart failure with preserved ejection fraction.
    Heart. 2025 Jun 19:heartjnl-2025-326328. doi: 10.1136/heartjnl-2025-326328.
    >> Share

  62. IWATSU K, Takabayashi K, Hamada T, Kubo T, et al
    Severity of mobility limitation and adverse outcomes in heart failure.
    Heart. 2025 Jun 18:heartjnl-2024-325120. doi: 10.1136/heartjnl-2024-325120.
    >> Share

    May 2025
  63. YAN C, Li H, Wan L, Liu A, et al
    Left atrial pressure normalisation by graded radiofrequency atrial septostomy in heart failure with preserved ejection fraction: a single-arm pilot study.
    Heart. 2025 May 27:heartjnl-2025-325929. doi: 10.1136/heartjnl-2025-325929.
    >> Share

  64. SONG Z, Wang SY, Qidong Z, Chen N, et al
    Catheter ablation versus medical rate control for persistent atrial fibrillation in older heart failure patients with reduced ejection fraction.
    Heart. 2025 May 20:heartjnl-2024-324668. doi: 10.1136/heartjnl-2024-324668.
    >> Share

  65. YAQOOB K, Naderi H, Thomson RJ, Aksentijevic D, et al
    Prognostic impact of albuminuria in early-stage chronic kidney disease on cardiovascular outcomes: a cohort study.
    Heart. 2025;111:506-512.
    >> Share

  66. CHRISTENSEN MK, Hyldgard VB, Madelaire C, Pedersen AK, et al
    Disparities in prescriptions among Danish heart failure patients: a national longitudinal cohort study.
    Heart. 2025 May 10:heartjnl-2024-325562. doi: 10.1136/heartjnl-2024-325562.
    >> Share

    April 2025
  67. MACLEAN R, Chen Y, Lumbers RT, Shah AD, et al
    Mineralocorticoid receptor antagonist (MRA) use in UK heart failure care: a national primary care cohort study.
    Heart. 2025 Apr 18:heartjnl-2024-325132. doi: 10.1136/heartjnl-2024-325132.
    >> Share

  68. HUANG Y, Zhang Y, Zhang Y, Xiang H, et al
    Hearing impairment, psychological distress, and incident heart failure: a prospective cohort study.
    Heart. 2025 Apr 8:heartjnl-2024-325394. doi: 10.1136/heartjnl-2024-325394.
    >> Share

    March 2025
  69. AL-MOHAMMAD A
    Iron deficiency, heart failure and ageing: what do we know?
    Heart. 2025 Mar 27:heartjnl-2024-325652. doi: 10.1136/heartjnl-2024-325652.
    >> Share

  70. LIU B, Wu X, Wang Y, Hu X, et al
    Association between cardiac cachexia and adverse outcomes in patients with heart failure: a meta-analysis of cohort studies.
    Heart. 2025 Mar 15:heartjnl-2024-325431. doi: 10.1136/heartjnl-2024-325431.
    >> Share

  71. XING F, Gao M, Wu Y, Liang W, et al
    Influence of depression trajectories in heart failure patients with preserved ejection fractions: a secondary analysis of adverse outcomes in the TOPCAT trial.
    Heart. 2025 Mar 15:heartjnl-2024-324505. doi: 10.1136/heartjnl-2024-324505.
    >> Share

  72. BEREZIN A
    Multifactorial management of complex comorbidity followed by heart failure, chronic kidney disease and type 2 diabetes mellitus: the way to overcome missed opportunities.
    Heart. 2025 Mar 4:heartjnl-2025-325804. doi: 10.1136/heartjnl-2025-325804.
    >> Share

  73. MOHAMED M, Dashtban A, Ali S, Oates T, et al
    Missed opportunities to manage complex comorbidity of heart failure, type 2 diabetes mellitus and chronic kidney disease: a retrospective cohort study.
    Heart. 2025 Mar 4:heartjnl-2024-325046. doi: 10.1136/heartjnl-2024-325046.
    >> Share

  74. HAGE C, Shahim A
    Importance of early diagnosis and implementation of guideline-directed therapies in heart failure: a message worth repeating, but we need to act!
    Heart. 2025 Mar 4:heartjnl-2024-325649. doi: 10.1136/heartjnl-2024-325649.
    >> Share

    February 2025
  75. MBANZE I, Spracklen TF, Jessen N, Damasceno A, et al
    Heart failure in low-income and middle-income countries.
    Heart. 2025 Feb 26:heartjnl-2024-324176. doi: 10.1136/heartjnl-2024-324176.
    >> Share

  76. LU Y, Chen J, Chen R, Lukwaro AF, et al
    Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, cohort study.
    Heart. 2025 Feb 26:heartjnl-2024-324679. doi: 10.1136/heartjnl-2024-324679.
    >> Share

  77. SQUIRE I, Kalra PR
    Cardiologists and recognition of iron deficiency in patients with heart failure.
    Heart. 2025 Feb 17:heartjnl-2024-325383. doi: 10.1136/heartjnl-2024-325383.
    >> Share

  78. SZE S, Squire I, Kalra PR, Cleland JG, et al
    Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial.
    Heart. 2025 Feb 12:heartjnl-2024-324908. doi: 10.1136/heartjnl-2024-324908.
    >> Share

  79. MOHAMED AA, Christensen DM, Mohammad M, Torp-Pedersen C, et al
    Prognostic implications of iron deficiency in patients with atrial fibrillation, with and without chronic heart failure.
    Heart. 2025 Feb 8:heartjnl-2024-325244. doi: 10.1136/heartjnl-2024-325244.
    >> Share

  80. TREWAREE S, Shantsila A, Lip GYH
    Pulse pressure and aortic valve peak velocity as new predictors of heart failure in patients post-myocardial infarction.
    Heart. 2025 Feb 6:heartjnl-2024-325513. doi: 10.1136/heartjnl-2024-325513.
    >> Share

  81. CULLER K, Zelnick LR, Mehta RC, de Sosa GR, et al
    The ICAM1 p.K56M variant and risk of heart failure in chronic kidney disease: the Chronic Renal Insufficiency Cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-325205. doi: 10.1136/heartjnl-2024-325205.
    >> Share

  82. WU Y, Zhao J, Chen C, Huang J, et al
    Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-324517. doi: 10.1136/heartjnl-2024-324517.
    >> Share

    January 2025
  83. WANG H, Gao C, Guignard-Duff M, Cole C, et al
    Inpatient versus outpatient diagnosis of heart failure across the spectrum of ejection fraction: a population cohort study.
    Heart. 2025 Jan 29:heartjnl-2024-324160. doi: 10.1136/heartjnl-2024-324160.
    >> Share

  84. MURAYAMA A
    Industry marketing payments to physicians and prescription patterns for sacubitril/valsartan in the USA.
    Heart. 2025;111:147-150.
    >> Share

  85. SIEGMUND AS, van Gelder IC, van Melle JP
    Atrial arrhythmia and heart failure in congenital heart disease: a pas de deux with consequences.
    Heart. 2025 Jan 9:heartjnl-2024-325262. doi: 10.1136/heartjnl-2024-325262.
    >> Share

  86. SU L, Li P, Li Z, Chen Z, et al
    Gaps in knowledge and management of iron deficiency in heart failure: a nationwide survey of cardiologists in China.
    Heart. 2025 Jan 9:heartjnl-2024-324887. doi: 10.1136/heartjnl-2024-324887.
    >> Share

    November 2024
  87. CEELEN DCH, Bracun V, van Essen BJ, Voors AA, et al
    Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure.
    Heart. 2024 Nov 29:heartjnl-2024-324486. doi: 10.1136/heartjnl-2024-324486.
    >> Share

  88. LAUWERS C, Troost E, De Meester P, Moons P, et al
    Atrial arrhythmia and heart failure in adult patients with congenital heart disease: a retrospective cohort study.
    Heart. 2024 Nov 7:heartjnl-2024-324417. doi: 10.1136/heartjnl-2024-324417.
    >> Share

  89. WANG J, Zhang Z, Sun Y, Yu B, et al
    Association of innate versus specific immunity with heart failure incidence: a prospective study.
    Heart. 2024 Nov 1:heartjnl-2024-324591. doi: 10.1136/heartjnl-2024-324591.
    >> Share

    October 2024
  90. ACHILLI F, Maggiolini S, Madotto F, Bassetti B, et al
    Granulocyte colony-stimulating factor for stem cell mobilisation in acute myocardial infarction: a randomised controlled trial.
    Heart. 2024 Oct 14:heartjnl-2024-323926. doi: 10.1136/heartjnl-2024-323926.
    >> Share

  91. SARRAZYN C, Fortuni F, Laenens D, Chua AP, et al
    Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation.
    Heart. 2024 Oct 4:heartjnl-2024-324526. doi: 10.1136/heartjnl-2024-324526.
    >> Share

    September 2024
  92. YU YL, Siwy J, An DW, Gonzalez A, et al
    Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.
    Heart. 2024;110:1180-1187.
    >> Share

    August 2024
  93. WONG J, Soh CH, Wang B, Marwick T, et al
    Long-term risk of heart failure in adult cancer survivors: a systematic review and meta-analysis.
    Heart. 2024 Aug 22:heartjnl-2024-324301. doi: 10.1136/heartjnl-2024-324301.
    >> Share

  94. GRAHAM FJ, Guha K, Cleland JG, Kalra PR, et al
    Treating iron deficiency in patients with heart failure: what, why, when, how, where and who.
    Heart. 2024 Aug 19:heartjnl-2022-322030. doi: 10.1136/heartjnl-2022-322030.
    >> Share

    April 2024
  95. CUTHBERT JJ, Soyiri I, Lomax SJ, Turgoose J, et al
    Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study.
    Heart. 2024 Apr 17:heartjnl-2023-323577. doi: 10.1136/heartjnl-2023-323577.
    >> Share

    March 2024
  96. MERCADE-BESORA N, Li X, Kolde R, Trinh NT, et al
    The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications.
    Heart. 2024 Mar 12:heartjnl-2023-323483. doi: 10.1136/heartjnl-2023-323483.
    >> Share

    February 2024
  97. HENDRIKS PM, van den Bosch AE, Kors JA, Geenen LW, et al
    Heart rate: an accessible risk indicator in adult congenital heart disease.
    Heart. 2024;110:402-407.
    >> Share

    January 2024
  98. DOHERTY DJ, Docherty KF, Gardner RS
    Review of the National Institute for Health and Care Excellence guidelines on chronic heart failure.
    Heart. 2024 Jan 8:heartjnl-2022-322164. doi: 10.1136/heartjnl-2022-322164.
    >> Share

    December 2023
  99. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
    Predictors of outcome in patients with moderate mixed aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
    >> Share

  100. SUC G, Cachier A, Hentic O, Bazire B, et al
    Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours.
    Heart. 2023;110:132-139.
    >> Share

  101. ALI MR, Lam CSP, Stromberg A, Hand SPP, et al
    Symptoms and signs in patients with heart failure: association with 3-month hospitalisation and mortality.
    Heart. 2023 Dec 1:heartjnl-2023-323295. doi: 10.1136/heartjnl-2023-323295.
    >> Share

    November 2023
  102. VAZIR A, Kapelios CJ
    Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene?
    Heart. 2023;109:1864-1870.
    >> Share

  103. CHOI S, Nah S, Cho YS, Moon I, et al
    Accuracy of visual estimation of ejection fraction in patients with heart failure using augmented reality glasses.
    Heart. 2023 Nov 8:heartjnl-2023-323067. doi: 10.1136/heartjnl-2023-323067.
    >> Share

  104. SANGHA V
    Augmenting reality in echocardiography.
    Heart. 2023 Nov 8:heartjnl-2023-323443. doi: 10.1136/heartjnl-2023-323443.
    >> Share

    October 2023
  105. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
    Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
    Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
    >> Share

  106. FERKH A, Clark A, Thomas L
    Left atrial phasic function: physiology, clinical assessment and prognostic value.
    Heart. 2023;109:1661-1669.
    >> Share

  107. SOTOMI Y, Tamaki S, Hikoso S, Nakatani D, et al
    Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction.
    Heart. 2023 Oct 12:heartjnl-2023-323059. doi: 10.1136/heartjnl-2023-323059.
    >> Share


  108. Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry.
    Heart. 2023 Oct 12:heartjnl-2023-323049. doi: 10.1136/heartjnl-2023-323049.
    >> Share

    September 2023
  109. OTTO CM
    Heartbeat: cardiopulmonary fitness as an explanation for the apparent obesity paradox in heart failure mortality risk.
    Heart. 2023;109:1499-1501.
    >> Share

  110. NEDEREND M, Kies P, Regeer MV, Vliegen HW, et al
    Tolerability and beneficial effects of sacubitril/valsartan on systemic right ventricular failure.
    Heart. 2023;109:1525-1532.
    >> Share

  111. FRITZ J, Belovari K, Ulmer H, Zaruba MM, et al
    Aetiology, ejection fraction and mortality in chronic heart failure: a mediation analysis.
    Heart. 2023 Sep 18:heartjnl-2023-322803. doi: 10.1136/heartjnl-2023-322803.
    >> Share

  112. ELTAYEB M, Squire I, Sze S
    Biomarkers in heart failure: a focus on natriuretic peptides.
    Heart. 2023 Sep 6:heartjnl-2020-318553. doi: 10.1136/heartjnl-2020-318553.
    >> Share

    August 2023
  113. PONNUSAMY SS, Syed T, Vijayaraman P
    Pacing induced cardiomyopathy: recognition and management.
    Heart. 2023;109:1407-1415.
    >> Share

  114. BRADLEY J, Schelbert EB, Bonnett LJ, Lewis GA, et al
    Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation.
    Heart. 2023 Aug 11:heartjnl-2023-322857. doi: 10.1136/heartjnl-2023-322857.
    >> Share

  115. GRAHAM FJ, Friday JM, Pellicori P, Greenlaw N, et al
    Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease.
    Heart. 2023;109:1294-1301.
    >> Share

  116. CHAN DZ, Grey C, Doughty RN, Lund M, et al
    Widening ethnic inequities in heart failure incidence in New Zealand.
    Heart. 2023 Aug 3:heartjnl-2023-322795. doi: 10.1136/heartjnl-2023-322795.
    >> Share

    July 2023
  117. BEGGS SAS, Wright GA, Gardner RS
    Primary prevention implantable cardioverter defibrillators for patients with heart failure.
    Heart. 2023 Jul 18:heartjnl-2022-321728. doi: 10.1136/heartjnl-2022-321728.
    >> Share

  118. DIBBEN GO, Hannay JR, Taylor RS
    Exercise training in heart failure.
    Heart. 2023 Jul 17:heartjnl-2022-321132. doi: 10.1136/heartjnl-2022-321132.
    >> Share

  119. LUMISH HS, Liang LW, Hasegawa K, Maurer MS, et al
    Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
    Heart. 2023 Jul 14:heartjnl-2023-322644. doi: 10.1136/heartjnl-2023-322644.
    >> Share

  120. OTTO CM
    Heartbeat: Questionable benefit of beta-blocker therapy more than one year after myocardial infarction in patients without heart failure or ventricular dysfunction.
    Heart. 2023;109:1123-1125.
    >> Share

  121. SCHOPS LB, Sengelov M, Modin D, Jorgensen PG, et al
    Parameters associated with improvement of systolic function in patients with heart failure.
    Heart. 2023 Jul 9:heartjnl-2023-322371. doi: 10.1136/heartjnl-2023-322371.
    >> Share

  122. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
    Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
    Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
    >> Share

    June 2023
  123. YOGESWARAN V, Hidano D, Diaz AE, Van Spall HGC, et al
    Regional variations in heart failure: a global perspective.
    Heart. 2023 Jun 23:heartjnl-2022-321295. doi: 10.1136/heartjnl-2022-321295.
    >> Share

  124. LAVIE CJ, Kokkinos P, Lin GM
    Obesity paradox is still alive in heart failure.
    Heart. 2023 Jun 20:heartjnl-2023-322797. doi: 10.1136/heartjnl-2023-322797.
    >> Share

  125. NGUYEN DD, Arnold SV
    Impact of frailty on disease-specific health status in cardiovascular disease.
    Heart. 2023;109:977-983.
    >> Share

  126. FUSCO F, Scognamiglio G
    Heart failure management in adults with congenital heart disease: are we on the 'right path'?
    Heart. 2023 Jun 8:heartjnl-2023-322807. doi: 10.1136/heartjnl-2023-322807.
    >> Share

  127. JONES NR, Ordonez-Mena JM, Roalfe AK, Taylor KS, et al
    Body mass index and survival in people with heart failure.
    Heart. 2023 Jun 8:heartjnl-2023-322459. doi: 10.1136/heartjnl-2023-322459.
    >> Share

  128. CARRERAS-MORA J, Simon-Ramon C, Vidal-Burdeus M, Rodriguez-Sotelo L, et al
    Subclinical congestion assessed by lung ultrasound in ST segment elevation myocardial infarction.
    Heart. 2023 Jun 7:heartjnl-2023-322690. doi: 10.1136/heartjnl-2023-322690.
    >> Share

    May 2023
  129. YOGESWARAN V, Wadden E, Szewczyk W, Barac A, et al
    A narrative review of heart failure with preserved ejection fraction in breast cancer survivors.
    Heart. 2023 May 31:heartjnl-2022-321859. doi: 10.1136/heartjnl-2022-321859.
    >> Share

  130. MORTON G, Moore J
    Systems of care for heart failure: bridging the divide between primary care and specialist services.
    Heart. 2023 May 5:heartjnl-2022-321757. doi: 10.1136/heartjnl-2022-321757.
    >> Share

  131. ISHAK D, Aktaa S, Lindhagen L, Alfredsson J, et al
    Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes.
    Heart. 2023 May 2:heartjnl-2022-322115. doi: 10.1136/heartjnl-2022-322115.
    >> Share

    April 2023
  132. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
    Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Heart. 2023;109:771-778.
    >> Share

  133. RAISI-ESTABRAGH Z, Cooper J, McCracken C, Crosbie EJ, et al
    Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer.
    Heart. 2023 Apr 18:heartjnl-2022-321888. doi: 10.1136/heartjnl-2022-321888.
    >> Share

  134. MARUT B, Charbonneau E, Curtis E, Donal E, et al
    Will computerised medical records and statistical tools really help us move towards precision medicine of heart failure with preserved ejection fraction?
    Heart. 2023 Apr 17:heartjnl-2023-322475. doi: 10.1136/heartjnl-2023-322475.
    >> Share

    March 2023
  135. JASINSKA-PIADLO A, Campbell P
    Management of patients with heart failure and preserved ejection fraction.
    Heart. 2023 Mar 22:heartjnl-2022-321097. doi: 10.1136/heartjnl-2022-321097.
    >> Share

  136. FORSYTH P, Beezer J, Bateman J
    Holistic approach to drug therapy in a patient with heart failure.
    Heart. 2023 Mar 10:heartjnl-2022-321764. doi: 10.1136/heartjnl-2022-321764.
    >> Share

  137. SCHLENKER KA, Steiner JM
    Expanding perspective: considering opioids in the management of dyspnoea in end-stage heart failure.
    Heart. 2023 Mar 10:heartjnl-2023-322436. doi: 10.1136/heartjnl-2023-322436.
    >> Share

  138. KOSTOPOULOS G, Doundoulakis I, Toulis KA, Karagiannis T, et al
    Prognostic models for heart failure in patients with type 2 diabetes: a systematic review and meta-analysis.
    Heart. 2023 Mar 10:heartjnl-2022-322044. doi: 10.1136/heartjnl-2022-322044.
    >> Share

  139. GAERTNER J, Fusi-Schmidhauser T, Stock S, Siemens W, et al
    Effect of opioids for breathlessness in heart failure: a systematic review and meta-analysis.
    Heart. 2023 Mar 6:heartjnl-2022-322074. doi: 10.1136/heartjnl-2022-322074.
    >> Share

    February 2023
  140. JORDAN C, Charman SJ, Batterham AM, Flynn D, et al
    Habitual physical activity levels of adults with heart failure: systematic review and meta-analysis.
    Heart. 2023 Feb 27:heartjnl-2022-321943. doi: 10.1136/heartjnl-2022-321943.
    >> Share

  141. WEIR RAP
    Management of hospitalised patients with heart failure admitted to non-cardiology services.
    Heart. 2023 Feb 27:heartjnl-2022-321720. doi: 10.1136/heartjnl-2022-321720.
    >> Share

  142. NADARAJAH R, Wu J, Hogg D, Raveendra K, et al
    Prediction of short-term atrial fibrillation risk using primary care electronic health records.
    Heart. 2023 Feb 9:heartjnl-2022-322076. doi: 10.1136/heartjnl-2022-322076.
    >> Share

    November 2022
  143. MARTIN DE MIGUEL I, Madhavan M, Miranda WR, Connolly HM, et al
    Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
    Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016